Stephen Sherwin, M.D.
Member of Biosante Pharmaceuticals (Canadian Family Pharmacy)
Dr. Stephen Sherwin contributes experience in pharmacology that spans over more than 30 years of practice. He is a venture partner at Third Rock Ventures, and before that Dr. Sherwin used to be a part of Cell Genesys in the role of Executive Officer. His early career days were spent working as a researcher at the National Cancer Institute, to later become a vice president of Genentech’s research team and the chairman for Ceregene which was later acquired by Sangamo Biosciences.
Dr. Stephen dedicated a large amount of time volunteering at Zuckerberg San Francisco General Hospital, a practice that consumes him totally, according to his own words. He sees his true vocation in helping those affected by serious illnesses, patients as well as their families, and takes active stance in multiple related initiatives, including informational support.